Literature DB >> 2403561

Cellular and subcellular localization of an Mr 64,000 protein autoantigen in insulin-dependent diabetes.

M R Christie1, D G Pipeleers, A Lernmark, S Baekkeskov.   

Abstract

Antibodies to an Mr 64,000 protein from human or rat islets have been detected at high frequency in newly diagnosed insulin-dependent diabetic patients. In this study, we show that the antigenic and amphiphilic properties of the rat islet Mr 64,000 protein resemble that of the human protein. We have analyzed the expression of the Mr 64,000 protein in populations of pancreatic beta and non-beta cells and in selected rat tissues by immunoprecipitation of [35S]methionine-radiolabeled proteins with sera from diabetic patients or from healthy control individuals. When islet cell populations enriched in beta or non-beta cells were tested for the expression of the Mr 64,000 antigen, the protein was primarily observed in the beta cells. On analyzing preparations of islets, liver, kidney, thyroid, adrenal, pituitary, spleen, and thymus, the protein could only be detected in islets. The protein was also characterized in terms of its subcellular localization by Percoll density gradient centrifugation and was recovered in a fraction enriched in the plasma membrane marker, 5'-nucleotidase. These results are consistent with a beta cell-restricted plasma membrane expression of the protein and support the hypothesis that this protein is a target antigen of beta cell-specific autoimmunity in insulin-dependent diabetes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403561

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Subcutaneous Insulin Administration: Sufficient Progress or Ongoing Need?

Authors:  Ronald J Pettis; Douglas Muchmore; Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2018-12-07

Review 2.  The immunologic insult in type 1 diabetes.

Authors:  M C Honeyman; L C Harrison
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function.

Authors:  J Seissler; B Hering; W Richter; M Glück; N Yassin; R G Bretzel; B O Boehm; K Federlin; W A Scherbaum
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

4.  Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase.

Authors:  M R Christie; J A Hollands; T J Brown; B K Michelsen; T L Delovitch
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.

Authors:  W Richter; J Endl; T H Eiermann; M Brandt; R Kientsch-Engel; C Thivolet; H Jungfer; W A Scherbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

6.  Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies.

Authors:  W Richter; T H Eiermann; J Endl; J Seissler; S Wolfahrt; M Brandt; H Jungfer; W A Scherbaum
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

7.  Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

Authors:  D L Kaufman; M G Erlander; M Clare-Salzler; M A Atkinson; N K Maclaren; A J Tobin
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

8.  Binding of antibodies in sera from Type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues. Evidence for antigenic and non-antigenic forms of the enzyme.

Authors:  M R Christie; T J Brown; D Cassidy
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

9.  GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion.

Authors:  A Reetz; M Solimena; M Matteoli; F Folli; K Takei; P De Camilli
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

10.  Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment.

Authors:  M R Christie; G Vohra; P Champagne; D Daneman; T L Delovitch
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.